DE602004032579D1 - Zusammensetzung für den tierischen verzehr sowie verfahren zur reduktion der map-kinaseaktivität - Google Patents

Zusammensetzung für den tierischen verzehr sowie verfahren zur reduktion der map-kinaseaktivität

Info

Publication number
DE602004032579D1
DE602004032579D1 DE602004032579T DE602004032579T DE602004032579D1 DE 602004032579 D1 DE602004032579 D1 DE 602004032579D1 DE 602004032579 T DE602004032579 T DE 602004032579T DE 602004032579 T DE602004032579 T DE 602004032579T DE 602004032579 D1 DE602004032579 D1 DE 602004032579D1
Authority
DE
Germany
Prior art keywords
weight
composition
omega
fatty acids
polyunsaturated fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004032579T
Other languages
English (en)
Inventor
Kathy Gross
Inke Paetau-Robinson
Korinn E Saker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Tech Intellectual Properties Inc
Original Assignee
Virginia Tech Intellectual Properties Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34632944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004032579(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Virginia Tech Intellectual Properties Inc filed Critical Virginia Tech Intellectual Properties Inc
Publication of DE602004032579D1 publication Critical patent/DE602004032579D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/22—Compounds of alkali metals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE602004032579T 2003-11-25 2004-11-24 Zusammensetzung für den tierischen verzehr sowie verfahren zur reduktion der map-kinaseaktivität Active DE602004032579D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52498103P 2003-11-25 2003-11-25
PCT/US2004/039852 WO2005051093A1 (en) 2003-11-25 2004-11-24 Composition for animal consumption and method for reducing map kinase activity

Publications (1)

Publication Number Publication Date
DE602004032579D1 true DE602004032579D1 (de) 2011-06-16

Family

ID=34632944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004032579T Active DE602004032579D1 (de) 2003-11-25 2004-11-24 Zusammensetzung für den tierischen verzehr sowie verfahren zur reduktion der map-kinaseaktivität

Country Status (14)

Country Link
US (2) US7744917B2 (de)
EP (4) EP2772140B1 (de)
JP (2) JP2007512023A (de)
CN (1) CN1905807B (de)
AT (1) ATE507726T1 (de)
AU (2) AU2004293110C1 (de)
BR (1) BRPI0416956A (de)
CA (1) CA2545645C (de)
DE (1) DE602004032579D1 (de)
DK (2) DK2260718T3 (de)
ES (2) ES2525729T3 (de)
RU (1) RU2387281C2 (de)
WO (1) WO2005051093A1 (de)
ZA (2) ZA200604193B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051093A1 (en) 2003-11-25 2005-06-09 Hill's Pet Nutrition, Inc. Composition for animal consumption and method for reducing map kinase activity
BRPI0519610A2 (pt) * 2004-12-30 2009-02-25 Hills Pet Nutrition Inc mÉtodos para melhorar a qualidade de vida de um animal idoso ou muito idoso, de um canino de raÇa regular ou pequena, idoso ou muito idoso, de um cço de raÇa grande idoso ou muito idoso, e de um gato idoso ou muito idoso
CA2623214C (en) * 2005-09-30 2011-07-26 Hill's Pet Nutrition, Inc. Methods for extending the shelf-life of food compositions containing polyunsaturated fatty acids
JP2009515906A (ja) * 2005-11-10 2009-04-16 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物の皮膚の健康および毛衣の質を改善するための組成物および方法
CA2731088C (en) * 2008-07-18 2015-09-22 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
AU2010273505B2 (en) * 2009-07-14 2013-07-25 Hill's Pet Nutrition, Inc. Pet food compositions including a sustained-release lipoic acid and methods of manufacture and use thereof
SG10201604560TA (en) * 2011-04-12 2016-07-28 Moerae Matrix Inc Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
JP2014530021A (ja) * 2011-10-14 2014-11-17 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ペットフード組成物の調製方法
EP2765865B1 (de) 2011-10-14 2017-07-05 Hill's Pet Nutrition, Inc. Verfahren zur herstellung einer lebensmittelzusammensetzung
AU2013404982B2 (en) 2013-11-05 2017-04-13 Hill's Pet Nutrition, Inc. Palatability enhancers for foods designed for dogs and cats with renal insufficiency
JP6611665B2 (ja) * 2016-05-06 2019-11-27 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ペットフード組成物の調製方法
US11206852B2 (en) * 2017-08-25 2021-12-28 Guardian Pet Food Company Compact nutrient dense freeze-dried pet food product
CA3122205A1 (en) * 2018-12-13 2020-06-18 Societe Des Produits Nestle Sa Methods for increasing fat oxidation or energy expenditure or satiety in an animal
JP2023507340A (ja) * 2019-12-19 2023-02-22 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド イヌ甲状腺機能低下症および他の自己免疫性状態の発症リスクを評価および低減するための試薬、キット、ならびに方法
US11559066B2 (en) 2019-12-19 2023-01-24 Hill's Pet Nutrition, Inc. Reagents, kits and methods for assessing and reducing risk of developing canine hypothyroidism and other autoimmune conditions

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202514A (en) 1963-07-15 1965-08-24 Gen Foods Corp Animal food and method of making the same
US5004624A (en) 1983-03-14 1991-04-02 Star-Kist Foods, Inc. Semi-moist pet food having free gravy and process for preparation thereof
US4997672A (en) 1987-03-10 1991-03-05 Virginia Commonwealth University Salt taste enhancer
US4997671A (en) 1988-09-09 1991-03-05 Nabisco Brands, Inc. Chewy dog snacks
US5114704A (en) 1989-05-30 1992-05-19 Nabisco Brands, Inc. Raw hide having a coating containing an inorganic pyrophosphate
US5419283A (en) 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5532010A (en) 1993-05-28 1996-07-02 Nabisco, Inc. Coated canine biscuits and preparation process
US5339771A (en) 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
US6074862A (en) 1995-12-20 2000-06-13 Signal Pharmaceuticals Inc. Mitogen-activated protein kinase kinase MEK6 and variants thereof
US5945418A (en) 1996-12-18 1999-08-31 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US5905089A (en) 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
AU745579B2 (en) 1997-10-20 2002-03-21 F. Hoffmann-La Roche Ag Bicyclic kinase inhibitors
US6039952A (en) * 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
EP1071429B1 (de) 1998-04-17 2002-01-30 Trustees Of Tufts College Map kinase-inhibitoren zur behandlung von durch tnf-alpha induzierte lipolyse- verursachte krankheiten
ES2203245T3 (es) * 1998-09-02 2004-04-01 Heska Corporation Metodo y composicion para proteger un carnivoro obligado de una enfermedad de metabolismo anormal de carbohidratos.
US6235524B1 (en) 1998-10-29 2001-05-22 Massachusetts Institute Of Technology Compositions and methods for screening agents that inhibit MAPK mediated anti-apoptotic signals
DE60011667T2 (de) 1999-11-24 2005-07-07 The Iams Company, Dayton Verfahren zur erhöhung der reproduzierenden leistung von hunden und katzen
US6379727B1 (en) 1999-12-29 2002-04-30 John F. Addy Flavoring system for pet foods
AU2001230605A1 (en) 2000-02-09 2001-08-20 Shionogi And Co., Ltd. Apoptosis inhibitor
CA2410960C (en) * 2000-06-01 2007-08-14 United Feeds, Inc. Animal food and method
US6410063B1 (en) * 2000-06-13 2002-06-25 Hill's Pet Nutrition, Inc. Composition and method
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US20030194478A1 (en) * 2002-04-12 2003-10-16 Davenport Gary Mitchell Dietary methods for canine performance enhancement
WO2005051093A1 (en) 2003-11-25 2005-06-09 Hill's Pet Nutrition, Inc. Composition for animal consumption and method for reducing map kinase activity

Also Published As

Publication number Publication date
EP3235384B1 (de) 2019-08-28
RU2006122524A (ru) 2008-01-10
JP2007512023A (ja) 2007-05-17
EP2260718A1 (de) 2010-12-15
EP1753302B1 (de) 2011-05-04
EP3235384A1 (de) 2017-10-25
CN1905807A (zh) 2007-01-31
EP1753302A1 (de) 2007-02-21
RU2387281C2 (ru) 2010-04-27
CN1905807B (zh) 2011-08-24
EP2260718B1 (de) 2014-10-22
CA2545645A1 (en) 2005-06-09
JP2012010705A (ja) 2012-01-19
US20100222279A1 (en) 2010-09-02
ZA200604193B (en) 2013-01-30
US20050208104A1 (en) 2005-09-22
EP2772140A1 (de) 2014-09-03
BRPI0416956A (pt) 2007-02-13
EP2772140B1 (de) 2017-04-05
JP5554758B2 (ja) 2014-07-23
AU2004293110A1 (en) 2005-06-09
DK1753302T3 (da) 2011-08-15
ATE507726T1 (de) 2011-05-15
AU2004293110C1 (en) 2011-06-02
ES2525729T3 (es) 2014-12-29
WO2005051093A1 (en) 2005-06-09
AU2011200043A1 (en) 2011-01-27
ES2365617T3 (es) 2011-10-07
AU2004293110B2 (en) 2010-10-07
US7744917B2 (en) 2010-06-29
ZA201208844B (en) 2013-07-31
CA2545645C (en) 2013-01-08
US8399411B2 (en) 2013-03-19
DK2260718T3 (en) 2014-11-17

Similar Documents

Publication Publication Date Title
ZA201208844B (en) Composition for animal consumption and method for reducing map kinase activity
Mnari et al. Fatty acids in muscles and liver of Tunisian wild and farmed gilthead sea bream, Sparus aurata
Shirai et al. Effect of season on the fatty acid composition and free amino acid content of the sardine Sardinops melanostictus
ATE480633T1 (de) Verfahren zur herstellung von mikrobiellem fett oder öl mit niedrigerem unverseifbarem anteil
Inhamuns et al. EPA and DHA quantification in two species of freshwater fish from Central Amazonia
DE69231793T2 (de) Mikrobielle öle und ihre verwendungen
WO2006085144A3 (en) Compositions containing high omega-3 and low saturated fatty acid levels
TR199801413A1 (xx) Bebek mamalar� i�in lipit kompozisyonu ve bunlar�n haz�rlanmas�
KR930005549A (ko) 발효액 아미노산을 기본으로 하는 동물 사료 보충제, 이의 제조방법 및 이의 용도
NZ510932A (en) Animal feed additive composition comprising at least two antimicrobial enzymes and one or more PUFAs for feeding to pigs, poultry, veal calves and fish
HK1068249A1 (en) Body fat level controllers
Ferreira et al. Enriching rotifers with “premium” microalgae. Isochrysis aff. galbana clone T-ISO
ATE354972T1 (de) Lipid mischungen und lebensmittel, enthaltend ölsäure und omega-6 fettsäuren, die die intramyozelluläre lipidkonzentration erhöhen
ATE307108T1 (de) Verfahren zur herstellung von cla-isomeren
Habeanu et al. Dietary Ecologic Camelina Oil: A Beneficial Source of n-3 PUFA in Muscle Tissue and Health Status in Finishing Pigs
PL1656034T3 (pl) Sole wapniowe kwasów tłuszczowych trans i polinienasyconych kwasów tłuszczowych zabezpieczone przed rozkładem w żwaczu
D’Arrigo et al. Effect of dietary linseed oil on pig hepatic tissue fatty acid composition and susceptibility to lipid peroxidation
DE69813600D1 (de) Verfahren zur erhöhung der konzentration von konjugierter linolsäure in milch und/oder fettgewebe eines wiederkäuers
GR1005769B (el) Μεθοδος παραγωγης προϊοντων μα βαση το κρεας, με αμεση και εμμεση ενσωματωση φυτικων και ζωικων λιπαρων ουσιων, ως φορεων ω-3 και ω-6 λιπαρων οξεων, και μεγιστη δυνατη υποκατασταση του ζωικου λιπους ως επισης και τη μεγιστη δυνατη περιεκτικοτητα σε πολυακορεστα λιπαρα οξεα (ω-3 και ω-6)
ATE416627T1 (de) Futter für legehennen zur herstellung von mit n-3 polyungesättigten fettsäuren und jod angereicherten eiern und fütterungsverfahren
DE60239514D1 (de) Verfahren zur Herstellung der Kalziumsalze von Fettsäuren aus Ölen mit erhöhtem Glyzeridgehalt
Jeong et al. Antioxidant activity of different lipid extracts from mackerel viscera
Yurin et al. Influence of food additives from fish milt roe and glycerin on productivity parameters of sturgeon fish
Shahidi et al. Extraction and concentration of omega-3 fatty acids of seal blubber
Basso et al. Fat quality of pigs from different production systems